🇨🇦 Alirocumab SAR236553 in Canada

Alirocumab SAR236553 (Alirocumab SAR236553) regulatory status in Canada.

Marketing authorisation

Alirocumab SAR236553 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Alirocumab SAR236553 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Alirocumab SAR236553 in Canada?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.